Last updated: May 29, 2026

Application No. 18/026,687

CYANINE COMPOUND AND PHOTOELECTRIC CONVERSION ELEMENT

Non-Final OA

Filed

Mar 16, 2023

Priority

Sep 25, 2020 — JP 2020-161368 +1 more

Examiner

KENYON, JOHN S

Art Unit

1625

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

Mitsubishi Gas Chemical Company Inc.

OA Round

1 (Non-Final)

Interview Optional

— +17.4% interview lift. Examiner has a relatively high allowance rate (80%); +17.4% interview lift. A written response may suffice.

Based on 933 resolved cases, 2023–2026

Examiner Intelligence

KENYON, JOHN S View full profile →

Grants 80% — above average

Career Allowance Rate

749 granted / 933 resolved

+20.3% vs TC avg

Strong +17% interview lift

Without

With

+17.4%

Interview Lift

resolved cases with interview

Typical timeline

2y 3m

Avg Prosecution

49 currently pending

Career history

974

Total Applications

across all art units

Statute-Specific Performance

§101

1.5%

-38.5% vs TC avg

§103

20.2%

-19.8% vs TC avg

§102

25.6%

-14.4% vs TC avg

§112

30.1%

-9.9% vs TC avg

Black line = Tech Center average estimate • Based on career data from 933 resolved cases

Prosecution Timeline

Mar 16, 2023

Application Filed

Apr 29, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/909,317

Patent 12637475

METHOD FOR PRODUCING NAPHTHYLSILOLE, NAPHTHYLSILOLE CONTAINING HETEROCYCLIC GROUP, AND GRAPHENE NANORIBBON CONTAINING HETEROCYCLIC GROUP

3y 7m to grant Granted May 26, 2026

18/383,144

Patent 12636279

Choline Salt Forms of an HIV Capsid Inhibitor

2y 7m to grant Granted May 26, 2026

18/558,726

Patent 12637413

FATTY ACID AMIDE HYDROLASE (FAAH) CLEAVABLE PRODRUGS OF THYROMIMETICS AND COMBINATION WITH PERIPHERALLY RESTRICTED FAAH INHIBITORS

2y 6m to grant Granted May 26, 2026

17/640,805

Patent 12630501

ANTI-FIBROTIC COMPOUNDS AND USE THEREOF

4y 2m to grant Granted May 19, 2026

17/441,453

Patent 12622432

PLANT CULTIVATION METHOD

4y 7m to grant Granted May 12, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

80%

Grant Probability

98%

With Interview (+17.4%)

2y 3m (~0m remaining)

Median Time to Grant

Low

PTA Risk

Based on 933 resolved cases by this examiner. Grant probability derived from career allowance rate.